The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen
Abstract
A critical step in cancer growth and metastasis is the dissolution of the extracellular matrix surrounding the malignant tumor, which leads to tumor cell invasion and dissemination. Type I collagen degradation involves the initial action of collagenolytic matrix metalloproteinases (MMP-1, -8, and -13) activated by MMP-3 (stromelysin-1). The role of interactive matrix serine proteinases (MSPs), including tumor-associated trypsinogens, has been unclear in collagenolysis. Now, we provide evidence that the major isoenzyme of human tumor-associated trypsinogens, trypsin-2, can directly activate three collagenolytic proMMPs as well as proMMP-3. These proMMP activations are inhibited by tumor-associated trypsin inhibitor (TATI). Furthermore, we demonstrate that trypsin-2 efficiently degrades native soluble type I collagen, which can be inhibited by TATI. However, cell culture studies showed that trypsin-2 transfection into the HSC-3 cell line did not result in MMP-1, -3, -8, and -13 activation but affected MMP-3 and -8 production at the protein level. These findings indicate that human trypsin-2 can be regarded as a potent tumor-associated matrix serine protease capable of being the initial activator of the collagenolytic MMP activation network as well as directly attacking type I collagen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The former encodes trypsin 2, involved in type I and II collagen degradation 27,28”
From Sex-specific gene expression signatures of calcific aortic valve stenosis in a large collection of human tissues (2026) · cites this paper as [27]
Citations
Cites
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Matrix Metalloproteinase-2 Is an Interstitial Collagenase
Aimes, R. T., & Quigley, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.5872 · Cited by 944
Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938
Matrix Metalloproteinase-8 Is Expressed in Rheumatoid Synovial Fibroblasts and Endothelial Cells
Hanemaaijer, R., Sorsa, T., Konttinen, Y. T., Ding, Y., Sutinen, M., Visser, H., van Hinsbergh, V. W. M., Helaakoski, T., Kainulainen, T., Rönkä, H., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31504 · Cited by 489
Self-citationStromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
Murphy, G., Cockett, M. I., Stephens, P. E., Smith, B. J., & Docherty, A. J. P. (1987) · Biochemical Journal · doi:10.1042/bj2480265 · Cited by 464
Kähäri, V.-M., & Saarialho-Kere, U. (1999) · Annals of Medicine · doi:10.3109/07853899909019260 · Cited by 408
Shamamian, P., Schwartz, J. D., Pocock, B. J. Z., Monea, S., Whiting, D., Marcus, S. G., & Mignatti, P. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10014 · Cited by 353
Airola, K., Karonen, T., Vaalamo, M., Lehti, K., Lohi, J., Kariniemi, A.-L., Keski-Oja, J., & Saarialho-Kere, U. K. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690417 · Cited by 227
Research works printed but not linked: 37
- Roberts R., 1995, Crit. Rev. Eukaryotic Gen. Expr., 5
- Birkedal-Hansen H., 1995, Curr. Opin. Cell. Biol. 7, 728−735
- Springman E. B., 1990, 87, 364−368
- Van Wart H. E., 1990, Proc. Natl. Acad. Sci. U.S.A. 87, 5578−5582
- Neurath H., 1984, Science 224, 350−357
- Sheele G., 1981, Gastroenterology 80, 461−473
- Wiegand U., 1993, Gene 136, 167−175
- Stenman U. H., 1988, Biol. Chem. Hoppe-Seyler, 369, 14
- Koivunen E., 1990, Cancer Res. 50, 2375−2378
- Kato Y., 1998, Eur. J. Cancer, 34
- Miyata S., 1998, Clin. Exp. Metastasis 16, 613−622
- Stenman U. H., 1990, Scand. J. Clin. Lab. Invest. Suppl., 201, 101
- Thomas G. T., 1999, Oral Oncol. 35, 227−233
- Suzuki K., 1990, Biochemistry 29, 10261−10270
- Sang Q. X., 1995, Biochim. Biophys. Acta, 1251, 108
- Wilhelm S. M., 1987, Proc. Natl. Acad. Sci. U.S.A. 84, 6725−6727
- Knäuper V., 1996, J. Biol. Chem., 271
- Lindy O., 1997, Arthritis Rheum. 40, 1391−1399
- Sorsa T., 1994, Ann. N.Y. Acad. Sci. 6, 112−131
- Boyum A., 1968, Scand. J. Clin. Lab. Invest. Suppl., 97, 89
- Hibbs M. S., 1984, Coll. Relat. Res. 4, 467−477
- Konttinen Y. T., 1998, Matrix Biol. 17, 585−601
- Baumann M., 1990, Anal. Biochem. 190, 198−208
- Bergmann U., 1989, J. Clin. Chem. Clin. Biochem., 27
- Itkonen O., 1990, J. Lab. Clin. Med., 115
- Koivunen E., 1991, Cancer Res. 51, 2107−2112
- Craik C. S., 1985, Science 228, 291−297
- Nagase H., 1990, Biochemistry 29, 5783−5789
- Tschesche H., 1992, Matrix Suppl. 1, 245−255
- Weiss S. J., 1989, N. Engl. J. Med., 320
- Cole A. A., 1996, J. Biol. Chem., 271
- Prikk K., 2001, 33, 437−444
- Kim M. H., 2001, Anticancer Res., 21, 50
- Bachmeier B. E., 2000, Biol. Chem. 381, 509−516
- Herman M. P., 2001, Circulation 104
- Kafienah W., 1998, Biochem. J., 220
- Abbreviations MMP, matrix metalloproteinase
Cited by
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
“The 51-kDa latent proenzyme can be activated by proteolytic removal of the prodomain by, for instance, the serine proteases trypsin-2 (Moilanen et al. 2003) and matriptase (Jin et al. 2006), yielding a 43-kDa active enzyme in humans.”
BackgroundSorsa, T., Tjäderhane, L., Konttinen, Y. T., Lauhio, A., Salo, T., Lee, H., Golub, L. M., Brown, D. L., & Mäntylä, P. (2006) · Annals of Medicine · doi:10.1080/07853890600800103 · Cited by 673
“Furthermore, human trypsin-2 can also directly degrade native interstitial type I and II collagens (71,72).”
BackgroundSelf-citationGelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Matrix metalloproteinases (MMPs) in oral diseases
Sorsa, T., Tjäderhane, L., & Salo, T. (2004) · Oral Diseases · doi:10.1111/j.1601-0825.2004.01038.x · Cited by 618
Self-citationTranscriptomic dissection of tongue squamous cell carcinoma
Ye, H., Yu, T., Temam, S., Ziober, B. L., Wang, J., Schwartz, J. L., Mao, L., Wong, D. T., & Zhou, X. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-69 · Cited by 344
“MMPs are a large family of proteinases which remodel extracellular matrix (ECM) components and play a significant role in tumor development, survival, invasion and metastasis [11-13].”
Background
Metadata
- Authors
- Moilanen, M., Sorsa, T., Stenman, M., Nyberg, P., Lindy, O., Vesterinen, J., Paju, A., Konttinen, Y. T., Stenman, U.-H., & Salo, T.
- Affiliations
- Oulu University Hospital (FI)
- Corresponding author
- Salo, Tuula
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-04-12
- Volume
- 42
- Issue
- 18
- Pages
- 5414-5420
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1967869198
- Cited by
- 111
- References
- 30
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 2 · 2014: 3 · 2013: 5 · 2012: 6
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- trypsinogen-2, matrix metalloproteinase activation, MMP-1, MMP-8, MMP-13, MMP-3, stromelysin-1, type I collagen degradation, tumor-associated trypsin inhibitor, extracellular matrix degradation, tumor invasion, HSC-3 cells
- MeSH terms
- Enzyme Activation, Enzyme Precursors, Extracellular Matrix, Humans, Serine Endopeptidases, Trypsin, Trypsin Inhibitor, Kazal Pancreatic, Trypsinogen, Tumor Cells, Cultured, Blotting, Western, Polymerase Chain Reaction, Collagenases, DNA Primers, Matrix Metalloproteinase 3, Matrix Metalloproteinase 1, Matrix Metalloproteinase 8, Collagen Type I, Matrix Metalloproteinase 13
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen. https://app.cochat.ai/papers/10.1021/bi020582s
- The paper
- Moilanen, M., Sorsa, T., Stenman, M., Nyberg, P., Lindy, O., Vesterinen, J., Paju, A., Konttinen, Y. T., Stenman, U.-H., & Salo, T. (2003). Tumor-Associated Trypsinogen-2 (Trypsinogen-2) Activates Procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen. Biochemistry. https://doi.org/10.1021/bi020582s
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.